Evidence map›Paper›PMID 41533699›Full record

ArticleBioinformatics (Oxford, England)2026

A case-based explainable graph neural network framework for mechanistic drug repositioning.

Adriana Carolina Gonzalez-Cavazos, Roger Tu, Meghamala Sinha, Andrew I Su

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Adriana Carolina Gonzalez-CavazosDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, United States.ORCID 0000-0001-9615-7157
Roger TuDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, United States.ORCID 0000-0002-7899-1604
Meghamala SinhaDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, United States.ORCID 0000-0002-6422-3313
Andrew I SuDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, United States.ORCID 0000-0002-9859-4104

Funding

Scripps Clinical and Translational Science HubUM1TR004407 · NCATS · SCRIPPS RESEARCH INSTITUTE, THE · PI Eric Jeffrey Topol · 2023 to 2026
$24.2M
Compound repositioning for Alzheimer's Disease using knowledge graphs, insurance claims data, and gene expression complementarityR01AG066750 · NIA · SCRIPPS RESEARCH INSTITUTE, THE · PI SU, ANDREW I · 2020 to 2024
$4.4M
Clinical and Translational Science UM1TR004407National Center for Advancing Translational Sciences (NCATS)National Institute on Aging (NIA) R01AG066750NCATS NIH HHS UM1 TR004407NIA NIH HHS R01 AG066750
6 · The paper itself

Abstract

Drug repositioning offers a cost-effective alternative to traditional drug development by identifying new uses for existing drugs. Recent advances leverage Graph Neural Networks (GNNs) to model complex biological data, showing promise in predicting novel drug-disease associations; however, these frameworks often lack explainability, a critical factor for validating predictions and understanding drug mechanisms. Here, we introduce Drug-Based Reasoning Explainer (DBR-X), an explainable GNN model that integrates a link-prediction module with a path-identification module to generate interpretable and faithful explanations. When benchmarked against other GNN-based link-prediction frameworks, DBR-X achieves superior performance in identifying known drug-disease associations, demonstrating higher accuracy across all evaluation metrics. The quality of DBR-X biological explanations was evaluated through multiple complementary approaches, including comparison with manually curated drug mechanisms, assessment of explanation faithfulness using deletion and insertion studies, and measurement of stability under graph perturbations. Together, these results show that DBR-X advances the state of the art in drug repositioning while providing multi-hop mechanistic explanations that can facilitate the translation of computational predictions into clinical applications. Availability and implementation: DBR-X package is freely accessible from online repository https://github.com/SuLab/DBR-X.

Indexed as

Computational BiologyDrug RepositioningGraph Neural NetworksHumans

Identifiers

PMID41533699
PMCPMC12891909

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.